Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Ascentage receives approval for phase Ib/II studies of APG-2575 in China

Nov. 24, 2020

Bio-Path studies BP-1002 in refractory or relapsed lymphoma and CLL

Nov. 23, 2020

Genfleet Therapeutics synthesizes KRAS inhibitors

Nov. 23, 2020

Beijing Jialin Pharmaceutical discloses new SMARCA2-targeting compounds

Nov. 23, 2020

Jiangsu Carefree Pharmaceutical synthesizes new tyrosine kinase receptors inhibitors

Nov. 20, 2020

Nanoparticle fights pancreatic cancer's chemo resistance

Nov. 20, 2020

Genoscience completes phase Ib study of GNS-561 in primary and secondary liver cancer

Nov. 19, 2020

PROTACs targeting CDK12 and/or a CDK9 synthesized at the Dana-Farber Cancer Institute

Nov. 19, 2020

Intermittent schedule of CH-5126766 shows activity across several RAS-RAF-driven cancers

Nov. 19, 2020

CDK4/6 inhibitors affect transcriptional landscape

Nov. 19, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 15, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Rethinking anorexia: A disorder of mind and metabolism
BioWorld Science
Anorexia nervosa (AN) is a complex and severe eating disorder that has long been considered a psychiatric condition driven by distorted body image and maladaptive...